Malaria Vaccine Market: By Type of Vaccine, By Target, By End user and Region Forecast 2019-2030

Malaria Vaccine Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Vaccine (Protein Vaccine, DNA Vaccines, Others), By Target (Pre-Erythrocytic Stage, Erythrocytic Stage, Combined Vaccines), By End user (Hospitals, Vaccination Centres, Others) and Region Forecast 2019-2030

Malaria Vaccine Market size was valued at US$ 81.51 billion in 2023 and is expected to reach US$ 239.84 million by 2030, at a significant CAGR of 33% from 2024-2030. Malaria is an infectious parasitic disease transmitted by a vector, female anopheles mosquito. Malaria produces recurrent attack of fever and chills. Malaria may lead to chronic conditions often death. Malaria may lead to several complications such as respiratory distress, severe headache and others.

Generally, malaria is diagnosed by the blood tests by investigating symptoms and presence of parasite in blood. Malaria diseases are widely spread in tropical and subtropical regions around the equator. Malaria's prevalence in tropical nations has been a source of concern for the entire world, causing millions of fatalities during the last ten years. Vaccine development is an essential component of effective intervention control.

In recent years, there has been a lot of study into new vaccine options. A diversified pipeline has been studied, based on ongoing malaria life-cycle research. Understanding the biology of the deadly human malaria parasites Plasmodium falciparum and Plasmodium vivax is critical for expanding opportunities in the malaria vaccine industry. New options in the malaria vaccine business have opened up thanks to generations of pre-erythrocytic vaccinations. This has sparked a flurry of interest from biotech firms. RTS,S/AS01 (RTS,S) is the most thoroughly investigated vaccine option for P. falciparum malaria prophylaxis.

Download Free Sample

Malaria Vaccine Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

33%

Largest Market

Asia-Pacific

Fastest Growing Market

Europe

Malaria Vaccine Market Dynamics

Global malaria vaccines market is mainly driven by increase in R&D activities of companies to develop vaccines for malaria. In addition, funding of the government and non-profit organizations and presence of pipeline vaccines and their expected commercialization anticipated to bolster the market growth further. Moreover, the prevalence of malaria, especially in the developing and underdeveloped countries in Asia and Africa, projected to fuel the global market during forecast period. However, complexity in vaccine development and regulatory approvals coupled with the high cost are expected to hinder the market growth during the forecast period.

Malaria Vaccine Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2024-2030
Market Size in 2023	US$ 81.51 billion
Market Size in 2030	US$ 239.84 million
Market CAGR	33%
By Type	Protein Vaccine DNA Vaccines Others
By Target	Pre-Erythrocytic Stage Erythrocytic Stage Combined Vaccines
By End User	Hospitals Vaccination Centres Others
By Region	North America Asia Pacific Europe Latin America Middle East and Africa

Key Features of the Report

The malaria vaccine market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global malaria vaccine market size was valued at US$ 81.51 billion in 2023 and is projected to grow at a CAGR of 33% from 2024-2030.

The Malaria vaccine market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Malaria vaccine market key players are GlaxoSmithKline Plc (U.K.), Sanaria Inc. (U.S.), Mymetics Corporation (Switzerland), Novavax, Inc. (U.S.)

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary

2.Global Malaria Vaccine Market Introduction

2.1.Global Malaria Vaccine Market - Taxonomy

2.2.Global Malaria Vaccine Market - Definitions

2.2.1.Type

2.2.2.Target

2.2.3.End User

2.2.4.Region

3.Global Malaria Vaccine Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Product Landscape

3.6. New Product Launches

3.7. Impact of COVID 19 on Market

4.Global Malaria Vaccine Market Analysis, 2019 - 2023 and Forecast 2024 - 2030

4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5.Global Malaria Vaccine Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

5.1. Protein Vaccine

5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. DNA Vaccines

5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Others

5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6.Global Malaria Vaccine Market By Target, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

6.1. Pre-Erythrocytic Stage

6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Erythrocytic Stage

6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Combined Vaccines

6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

7.Global Malaria Vaccine Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

7.1. Hospitals

7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Vaccination Centres

7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

8.Global Malaria Vaccine Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

8.1. North America

8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia Pacific (APAC)

8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Middle East and Africa (MEA)

8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Latin America

8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)

8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

9.North America Malaria Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.1.1.Protein Vaccine

9.1.2.DNA Vaccines

9.1.3.Others

9.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.2.1.Pre-Erythrocytic Stage

9.2.2.Erythrocytic Stage

9.2.3.Combined Vaccines

9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.3.1.Hospitals

9.3.2.Vaccination Centres

9.3.3.Others

9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

9.4.1.United States of America (USA)

9.4.2.Canada

10.Europe Malaria Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.1.1.Protein Vaccine

10.1.2.DNA Vaccines

10.1.3.Others

10.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.2.1.Pre-Erythrocytic Stage

10.2.2.Erythrocytic Stage

10.2.3.Combined Vaccines

10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.3.1.Hospitals

10.3.2.Vaccination Centres

10.3.3.Others

10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.4.1.Germany

10.4.2.France

10.4.3.Italy

10.4.4.United Kingdom (UK)

10.4.5.Spain

11.Asia Pacific (APAC) Malaria Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.1.1.Protein Vaccine

11.1.2.DNA Vaccines

11.1.3.Others

11.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.2.1.Pre-Erythrocytic Stage

11.2.2.Erythrocytic Stage

11.2.3.Combined Vaccines

11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.3.1.Hospitals

11.3.2.Vaccination Centres

11.3.3.Others

11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.4.1.China

11.4.2.India

11.4.3.Australia and New Zealand (ANZ)

11.4.4.Japan

11.4.5.Rest of APAC

12.Middle East and Africa (MEA) Malaria Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.1.1.Protein Vaccine

12.1.2.DNA Vaccines

12.1.3.Others

12.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.2.1.Pre-Erythrocytic Stage

12.2.2.Erythrocytic Stage

12.2.3.Combined Vaccines

12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.3.1.Hospitals

12.3.2.Vaccination Centres

12.3.3.Others

12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.4.1.GCC Countries

12.4.2.South Africa

12.4.3.Rest of MEA

13.Latin America Malaria Vaccine Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)

13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.1.1.Protein Vaccine

13.1.2.DNA Vaccines

13.1.3.Others

13.2. Target Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.2.1.Pre-Erythrocytic Stage

13.2.2.Erythrocytic Stage

13.2.3.Combined Vaccines

13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.3.1.Hospitals

13.3.2.Vaccination Centres

13.3.3.Others

13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.4.1.Brazil

13.4.2.Mexico

13.4.3.Rest of LA

14. Competition Landscape

14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)

14.2.1.GlaxoSmithKline Plc (U.K.)

14.2.2.Sanaria Inc. (U.S.)

14.2.3.Mymetics Corporation (Switzerland)

14.2.4.Novavax, Inc. (U.S.)

15. Research Methodology

16. Appendix and Abbreviations

Key Market Players

GlaxoSmithKline Plc (U.K.)
Sanaria Inc. (U.S.)
Mymetics Corporation (Switzerland)
Novavax, Inc. (U.S.)

Related Industry Reports

Malaria Testing Market

Global Companion Animal Vaccines Market

Global Childhood Vaccines Market

Global Anthrax Vaccine Market